News Snapshot:
Stock futures edged down in the early hours of Tuesday, ahead of important economic data releases later in the day. Here are some of Tuesday's biggest stock movers in premarket trading: Biggest stock gainers Immunovant (NASDAQ:IMVT) shares climbed 49% after a Phase 1 clinical trial in healthy adults showed dose-dependent reductions in Immunoglobulin G from subcutaneously administered doses of IMVT-1402. The results are consistent with previous non-human primate studies. The initial MAD study results showed a 63% mean total IgG reduction from baseline, with no decrease in serum albumin or LDL-C. Roivant Sciences (ROIV) shares rose over 17%. Pliant Therapeutics...